"Chemokine CXCL2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is synthesized by activated MONOCYTES and NEUTROPHILS. It has specificity for CXCR2 RECEPTORS.
| Descriptor ID |
D054426
|
| MeSH Number(s) |
D12.644.276.374.200.120.100 D12.644.276.374.200.600.940 D12.776.467.374.200.120.100 D12.776.467.374.200.600.940 D23.125.300.120.100 D23.125.300.600.940 D23.469.200.120.100 D23.469.200.600.940 D23.529.374.200.120.100 D23.529.374.200.600.940
|
| Concept/Terms |
Chemokine CXCL2- Chemokine CXCL2
- CXCL2, Chemokine
- LDNCF-2
- Macrophage Inflammatory Protein 2
- Macrophage Inflammatory Protein-2alpha
- Inflammatory Protein-2alpha, Macrophage
- Macrophage Inflammatory Protein 2alpha
- Chemokine (C-X-C Motif) Ligand 2
- MIP-2alpha
- MIP 2alpha
- MIP2alpha
- CXCL2 Chemokine
- Chemokine, CXCL2
- MIP-2 Chemokine
- Chemokine, MIP-2
- MIP 2 Chemokine
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL2".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL2".
This graph shows the total number of publications written about "Chemokine CXCL2" by people in this website by year, and whether "Chemokine CXCL2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL2" by people in Profiles.
-
ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer. Clin Cancer Res. 2017 Jan 15; 23(2):549-561.
-
Induction of chemokines and prostaglandin synthesis pathways in luteinized human granulosa cells: potential role of luteotropin withdrawal and prostaglandin F2a in regression of the human corpus luteum. Reprod Biol. 2015 Dec; 15(4):247-56.
-
Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury. Respir Res. 2012 Jan 18; 13:4.
-
Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT). PLoS Genet. 2011 Jun; 7(6):e1002108.
-
Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol. 2010 Apr 15; 221(1-2):46-52.
-
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology. 2008 Nov; 135(5):1624-1635.e24.
-
Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med. 2008 Sep 15; 178(6):605-17.
-
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis. 2008 Jul 15; 198(2):176-85.
-
C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J Immunol. 2007 Feb 01; 178(3):1819-28.
-
CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation. J Clin Invest. 2006 Oct; 116(10):2757-66.